AJP - Renal Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (January 7, 2003). doi:10.1152/ajprenal.00256.2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
284/3/F525    most recent
00256.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilcox, C. S.
Right arrow Articles by Welch, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilcox, C. S.
Right arrow Articles by Welch, W. J.
Submitted on July 16, 2002
Accepted on November 5, 2002

Thromboxane synthase and TP receptor mRNA in rat kidney and brain: effects of salt intake and ANG II

Christopher S. Wilcox1* and William J. Welch1

1 Division of Nephrology and Hypertension and Center for Hypertension and Renal Disease Research, Georgetown University Medical Center, Washington, DC, USA

* To whom correspondence should be addressed. E-mail: wilcoxch{at}georgetown.edu.

A TP receptor mimetic causes salt-sensitive hypertension and renal afferent arteriolar vasoconstriction. TP-R mediate effects of Ang II on renal vascular resistance and drinking. Therefore, we investigated the hypothesis that TxA2 synthase (TxA2-S) and/or TP-R expression is regulated by salt and/or Ang II. Methods: Rats (n=6) received high salt (HS) or low salt (LS) diets. Additional HS received Ang II and additional HS and LS received the AT1 receptor (AT1-R) antagonist, losartan. Results: Excretion of TxB2 by conscious rats was increased by HS, compared to LS (LS, 48 ± 5 vs. 126 ± 10 pmol.24h-1; p<0.01). The mRNA abundance for TP-R (relative to {beta}-actin) in kidney cortex was enhanced 30% by HS (p<0.001) and was reduced 30% by Ang II (p<0.001). However, during losartan, the effects of salt were reversed; mRNA more than doubled during LS (p<0.001). Likewise, the mRNA abundance for TP-R in the brain stem was reduced by 50% by Ang II (p<0.001) and, during losartan, was was almost doubled by LS (p<0.001). The mRNA abundance for TxA2-S in the kidney cortex also was increased many fold by HS (p<0.001). In contrast, the mRNA for TxA2-S in the brain was unaffected by salt. Ang II did not affect TxA2-S at either site. During losartan, TxA2-S increased modestly with LS in the brain stem. Conclusions: mRNA for TP-R in kidney cortex and brain stem are suppressed by Ang II acting on AT1-R. In the absence of AT1-R, expression of TP-R at both sites is enhanced by LS. In contrast, Ang II does not affect the mRNA abundance for TxA2-S. Expression of TxA2-S is enhanced by HS in the kidney cortex, but by LS in the brain stem only during losartan. Thus TP-R is strongly dependent on Ang II acting on AT1-R, whereas TxA2-S is regulated differentially in the kidney cortex and brain stem by salt intake.




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Araujo and W. J. Welch
Cyclooxygenase 2 inhibition suppresses tubuloglomerular feedback: roles of thromboxane receptors and nitric oxide
Am J Physiol Renal Physiol, April 1, 2009; 296(4): F790 - F794.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. Sebekova, T. Eifert, A. Klassen, A. Heidland, and K. Amann
Renal Effects of S18886 (Terutroban), a TP Receptor Antagonist, in an Experimental Model of Type 2 Diabetes
Diabetes, April 1, 2007; 56(4): 968 - 974.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Z. Qi, H. Cai, J. D. Morrow, and M. D. Breyer
Differentiation of Cyclooxygenase 1- and 2-Derived Prostanoids in Mouse Kidney and Aorta
Hypertension, August 1, 2006; 48(2): 323 - 328.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. S. Wilcox
Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension?
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2005; 289(4): R913 - R935.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
W. J. Welch
Effects of isoprostane on tubuloglomerular feedback: roles of TP receptors, NOS, and salt intake
Am J Physiol Renal Physiol, April 1, 2005; 288(4): F757 - F762.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. Wang, T. Chabrashvili, and C. S. Wilcox
Enhanced Contractility of Renal Afferent Arterioles From Angiotensin-Infused Rabbits: Roles of Oxidative Stress, Thromboxane Prostanoid Receptors, and Endothelium
Circ. Res., June 11, 2004; 94(11): 1436 - 1442.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1976 by the American Physiological Society.